FOR IMMEDIATE RELEASE
Mike Armitage, Director of Marketing & Communications
510.346.6800 ext 112
The AVLS Releases Revised Treatment Guidelines
Consensus document for the treatment of superficial venous disease of the lower leg
San Leandro, CA – April 28, 2015 – The American Vein & Lymphatic Society (AVLS) recently released revised guidelines for the treatment of superficial venous disease of the lower leg. Combining the comprehensive 2011 review by Peter Gloviczki, MD et al* with current studies, the AVLS’s consensus of experts prepared a guidelines document, which reflects evidenced-based recommendations and standards of care.
The guidelines incorporate the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to evaluate the efficacy of treatments. CEAP and VCSS are also employed to introduce the concept of “medically significant venous insufficiency,” in order to eliminate confusion around “cosmetic” or “not medically necessary” treatments.
“Vein care has advanced more in the last 10 years that in the last two centuries combined,” stated Mark Forestall, AVLS President. “This poses a challenge for insurers and payers. These guidelines are meant to coalesce fragmented and inconsistent medical necessity policy across the U.S.”
The guidelines arm vein care practitioners with a consensus document along with CPT/HCPCS and ICD-9 codes that can be referenced in the case of denial of reimbursement. Providers are encouraged to send the guidelines document to their local payers and insurance companies.
To download a copy of the Treatment of Superficial Venous Disease of the Lower Leg guidelines, please visit www. phlebology.org/member-resources/clinical-guidelines. If you have questions about the guidelines or need clarification, contact the AVLS via email at [email protected] or by phone at 510.346.6800.
About the American Vein & Lymphatic Society
The American Vein & Lymphatic Society (AVLS) is the largest association in the United States for physicians and allied health professionals concerned with the diagnosis and treatment of venous disorders, such as varicose and spider veins, venous ulcers and DVT. Comprised of more than 2,000 members, the AVLS is a forum to exchange medical knowledge, best practices and the latest treatment options, as well as offering continuing live and online education and training aimed at improving the quality of patient care. For nearly 30 years, the AVLS has been an advocate for the advancement of vein care through education, resources and research.
For more information about the American Vein & Lymphatic Society, visit www.phlebology.org.
*(J Vasc Surg. 2011 May;53(5 Suppl):2S-48S. doi: 10.1016/j.jvs.2011.01.079.)